Search - tctmd.com

Displaying 41 - 57 of 57

Sort: Relevancy | Date

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Todd Neale

March 16, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Daily News

Better Adherence to Guideline Advice Pays Off After Acute MI

Yael L. Maxwell

March 11, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

Presentation JIM 2020

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Presenter: Dominick Angiolillo

February 13, 2020

News Daily News

Complete PFO Closure May Be Key for Migraine Reduction

Todd Neale

February 04, 2020

News Daily News

Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results

Michael O'Riordan

January 27, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

CME

Advertisement

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Better Adherence to Guideline Advice Pays Off After Acute MI

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs

Complete PFO Closure May Be Key for Migraine Reduction

Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

The Biggest News of 2019: TCTMD’s Top 10

Aspirin for the Interventionalist: More Than Meets the Eye

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content